Sait Terzi
Research Subjects
Sait Terzi has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Kemal Yesilcimen
Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey
14 shared publicationsTamer Akbulut
11 shared publicationsAyşe Emre
Division of Cardiology, Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Research and Training Hospital, Tıbbiye Street No:13, Kadıköy, Istanbul, Turkey
9 shared publicationsNurten Sayar
Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey
8 shared publicationsTuba Bilsel
Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey
8 shared publicationsFigen Ciloglu
Genlab Medical Diagnostics and Research Laboratory
6 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50738
Early clinical and hemodynamic outcomes of SAVR, Ozaki neocuspidization, and TAVI
Aortic stenosis is a common valvular heart disease associated with substantial morbidity and mortality if left untreated. Surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI), and autologous pericardial aortic valve reconstruction (Ozaki procedure) represent alternative interventional strategies, but direct real-world comparisons remain limited. This study evaluated early clinical and 6-month hemodynamic outcomes following these 3 treatment approaches. This retrospective single-center observational study included 153 consecutive patients with severe aortic stenosis treated between December 2020 and March 2022 (SAVR, n = 67; Ozaki, n = 31; TAVI, n = 55). Early mortality was the primary clinical outcome, and 6-month mean transvalvular gradient was the primary echocardiographic outcome. Other clinical and echocardiographic outcomes were considered secondary or exploratory. Multivariable regression, analysis of covariance, and separate pairwise propensity-score matching models were used to account for baseline differences. Propensity scores were estimated using age, sex, EuroSCORE II, chronic kidney disease, and coronary artery disease. TAVI patients were older and had higher operative risk. No statistically significant differences were detected among the groups in early mortality, stroke, or postoperative dialysis. Permanent pacemaker implantation was more frequent after TAVI, while prolonged intensive care unit stay also differed among treatment groups. At 6 months, the Ozaki group showed favorable hemodynamic parameters, including lower mean transvalvular gradients and maximum transvalvular velocity. However, 6-month echocardiographic follow-up was incomplete, and these findings should be considered exploratory given the small Ozaki cohort, baseline differences, and observational study design. SAVR, Ozaki neocuspidization, and TAVI showed distinct early clinical and hemodynamic profiles in this real-world observational cohort. No statistically significant differences were detected in several major early clinical outcomes, although the study was not sufficiently powered to establish equivalent safety or exclude clinically meaningful differences. The favorable short-term hemodynamic findings observed with the Ozaki procedure should be considered hypothesis-generating. Larger prospective studies with longer follow-up are needed to further evaluate comparative clinical outcomes, hemodynamic performance, and durability.
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50738
Open AccessEarly clinical and hemodynamic outcomes of SAVR, Ozaki neocuspidization, and TAVI
Aortic stenosis is a common valvular heart disease associated with substantial morbidity and mortality if left untreated. Surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI), and autologous pericardial aortic valve reconstruction (Ozaki procedure) represent alternative interventional strategies, but direct real-world comparisons remain limited. This study evaluated early clinical and 6-month hemodynamic outcomes following these 3 treatment approaches. This retrospective single-center observational study included 153 consecutive patients with severe aortic stenosis treated between December 2020 and March 2022 (SAVR, n = 67; Ozaki, n = 31; TAVI, n = 55). Early mortality was the primary clinical outcome, and 6-month mean transvalvular gradient was the primary echocardiographic outcome. Other clinical and echocardiographic outcomes were considered secondary or exploratory. Multivariable regression, analysis of covariance, and separate pairwise propensity-score matching models were used to account for baseline differences. Propensity scores were estimated using age, sex, EuroSCORE II, chronic kidney disease, and coronary artery disease. TAVI patients were older and had higher operative risk. No statistically significant differences were detected among the groups in early mortality, stroke, or postoperative dialysis. Permanent pacemaker implantation was more frequent after TAVI, while prolonged intensive care unit stay also differed among treatment groups. At 6 months, the Ozaki group showed favorable hemodynamic parameters, including lower mean transvalvular gradients and maximum transvalvular velocity. However, 6-month echocardiographic follow-up was incomplete, and these findings should be considered exploratory given the small Ozaki cohort, baseline differences, and observational study design. SAVR, Ozaki neocuspidization, and TAVI showed distinct early clinical and hemodynamic profiles in this real-world observational cohort. No statistically significant differences were detected in several major early clinical outcomes, although the study was not sufficiently powered to establish equivalent safety or exclude clinically meaningful differences. The favorable short-term hemodynamic findings observed with the Ozaki procedure should be considered hypothesis-generating. Larger prospective studies with longer follow-up are needed to further evaluate comparative clinical outcomes, hemodynamic performance, and durability.
- 10 June 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (2) , 340-344
Intravascular lithotripsy for severe underexpansion of overlapping stents in heavily calcified right coronary artery: A case report
Stent underexpansion due to severe calcification remains a significant challenge in percutaneous coronary intervention, particularly in patients with overlapping stents. We aimed to demonstrate the efficacy of intravascular lithotripsy in managing refractory stent underexpansion when conventional techniques fail.A 71-year-old male with multiple cardiovascular risk factors and prior coronary artery bypass grafting presented with recurrent angina due to severe underexpansion of overlapping stents in the mid-right coronary artery. Despite aggressive preparation with non-compliant and cutting balloons across multiple sessions, adequate stent expansion could not be achieved. Intravascular ultrasound revealed circumferential calcification extending 270 degrees around the vessel with double-layered underexpanded stents. Intravascular lithotripsy was employed followed by high-pressure balloon dilatation to achieve optimal stent expansion. The patient tolerated the procedure without complications and reported complete resolution of anginal symptoms at post-discharge follow-up.This case demonstrates that intravascular lithotripsy is a highly effective and safe treatment option for severe stent underexpansion in the setting of heavy circumferential calcification when conventional balloon-based techniques fail.
- 10 June 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (2) , 340-344
Intravascular lithotripsy for severe underexpansion of overlapping stents in heavily calcified right coronary artery: A case report
Stent underexpansion due to severe calcification remains a significant challenge in percutaneous coronary intervention, particularly in patients with overlapping stents. We aimed to demonstrate the efficacy of intravascular lithotripsy in managing refractory stent underexpansion when conventional techniques fail.A 71-year-old male with multiple cardiovascular risk factors and prior coronary artery bypass grafting presented with recurrent angina due to severe underexpansion of overlapping stents in the mid-right coronary artery. Despite aggressive preparation with non-compliant and cutting balloons across multiple sessions, adequate stent expansion could not be achieved. Intravascular ultrasound revealed circumferential calcification extending 270 degrees around the vessel with double-layered underexpanded stents. Intravascular lithotripsy was employed followed by high-pressure balloon dilatation to achieve optimal stent expansion. The patient tolerated the procedure without complications and reported complete resolution of anginal symptoms at post-discharge follow-up.This case demonstrates that intravascular lithotripsy is a highly effective and safe treatment option for severe stent underexpansion in the setting of heavy circumferential calcification when conventional balloon-based techniques fail.
- Open Access
- 8 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Cardiac biomarkers combined with neuroimaging localization predict long-term outcomes in acute stroke patients
Cardiac biomarker elevation is common after stroke, but its relationship with stroke localization and long-term outcomes remains incompletely characterized. This prospective observational cohort study enrolled 695 patients (380 ischemic stroke, 135 TIA, 180 hemorrhagic stroke) from October 2020 to July 2023. High-sensitivity cardiac troponin I (hs-cTnI), NT-proBNP, and CK-MB were measured at admission and at 12–24 h. Ischemic strokes were categorized by localization (insular involvement, anterior non-insular, posterior circulation, subcortical-only). Primary outcomes were 1-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Biomarker elevations varied significantly by stroke type and localization. Hemorrhagic stroke showed the highest hs-cTnI (median 28.7 ng/L) and troponin elevation rate (54.4%). Among ischemic strokes, insular involvement demonstrated the highest biomarker levels (hs-cTnI 45.8 ng/L, NT-proBNP 892 pg/mL, troponin elevation 73.9%; all p < 0.001 versus other localizations). At 1 year, overall mortality was 20.4% and MACCE 31.4%. Elevated troponin independently predicted mortality (HR 3.24, 95% CI 2.18–4.82), MACCE (HR 2.86), and recurrent stroke (HR 1.92). A synergistic interaction between troponin elevation and insular involvement was identified for mortality (interaction HR 2.15, p = 0.029) and MACCE (interaction HR 1.84, p = 0.016). Hs-cTnI demonstrated good discriminative ability (AUC 0.782 for mortality, 0.745 for MACCE). Cardiac biomarker elevation, particularly in insular strokes, independently predicts adverse outcomes. Routine biomarker assessment combined with stroke localization data may enhance risk stratification and guide targeted interventions.
- 8 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessCardiac biomarkers combined with neuroimaging localization predict long-term outcomes in acute stroke patients
Cardiac biomarker elevation is common after stroke, but its relationship with stroke localization and long-term outcomes remains incompletely characterized. This prospective observational cohort study enrolled 695 patients (380 ischemic stroke, 135 TIA, 180 hemorrhagic stroke) from October 2020 to July 2023. High-sensitivity cardiac troponin I (hs-cTnI), NT-proBNP, and CK-MB were measured at admission and at 12–24 h. Ischemic strokes were categorized by localization (insular involvement, anterior non-insular, posterior circulation, subcortical-only). Primary outcomes were 1-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Biomarker elevations varied significantly by stroke type and localization. Hemorrhagic stroke showed the highest hs-cTnI (median 28.7 ng/L) and troponin elevation rate (54.4%). Among ischemic strokes, insular involvement demonstrated the highest biomarker levels (hs-cTnI 45.8 ng/L, NT-proBNP 892 pg/mL, troponin elevation 73.9%; all p < 0.001 versus other localizations). At 1 year, overall mortality was 20.4% and MACCE 31.4%. Elevated troponin independently predicted mortality (HR 3.24, 95% CI 2.18–4.82), MACCE (HR 2.86), and recurrent stroke (HR 1.92). A synergistic interaction between troponin elevation and insular involvement was identified for mortality (interaction HR 2.15, p = 0.029) and MACCE (interaction HR 1.84, p = 0.016). Hs-cTnI demonstrated good discriminative ability (AUC 0.782 for mortality, 0.745 for MACCE). Cardiac biomarker elevation, particularly in insular strokes, independently predicts adverse outcomes. Routine biomarker assessment combined with stroke localization data may enhance risk stratification and guide targeted interventions.
- 5 April 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (7) , 2261-2274
The HALP Score and Its Association With Coronary Collateral Circulation Development in Chronic Total Occlusion Patients
Background: Coronary collateral circulation plays a crucial compensatory role in patients with chronic total occlusion (CTO) by providing alternative blood flow pathways. The HALP score (hemoglobin, albumin, lymphocyte, and platelet) integrates systemic inflammation and nutritional status, but its relationship with collateral development in CTO patients remains unexplored. Aims: This study aimed to evaluate the association between HALP score and coronary collateral circulation quality assessed by Werner classification in CTO patients. Methods: This retrospective cross‐sectional study included 240 consecutive CTO patients who underwent coronary angiography. HALP score was calculated using the formula: hemoglobin (g/L) × albumin (g/L) × lymphocytes (/μL)/platelets (/μL). Collateral circulation was graded using the Werner classification (CC0‐CC3), with good collateral defined as a CC score ≥ 2. Correlation analysis, ROC curve analysis, and multivariate logistic regression were performed to assess the relationship between HALP score and collateral circulation. Results: The median HALP score was 4.20 (IQR: 2.68−5.68). A significant positive correlation was observed between HALP score and Werner grade ( r = 0.807, p < 0.001, R ² = 0.652). Median HALP scores increased progressively across Werner grades: CC0 (1.62), CC1 (3.20), CC2 (4.80), and CC3 (7.70). In multivariate analysis, the HALP score was significantly associated with good collateral circulation (OR: 3.762, 95% CI: 2.182−6.486, p < 0.001). The optimal cutoff of 3.509 demonstrated good diagnostic performance with 90.7% sensitivity and 66.7% specificity (AUC: 0.885). Conclusions: HALP score is significantly associated with coronary collateral circulation development in CTO patients. This simple, cost‐effective biomarker appears promising for risk stratification in this population based on this preliminary analysis, though prospective validation is needed before clinical application.
- 5 April 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (7) , 2261-2274
The HALP Score and Its Association With Coronary Collateral Circulation Development in Chronic Total Occlusion Patients
Background: Coronary collateral circulation plays a crucial compensatory role in patients with chronic total occlusion (CTO) by providing alternative blood flow pathways. The HALP score (hemoglobin, albumin, lymphocyte, and platelet) integrates systemic inflammation and nutritional status, but its relationship with collateral development in CTO patients remains unexplored. Aims: This study aimed to evaluate the association between HALP score and coronary collateral circulation quality assessed by Werner classification in CTO patients. Methods: This retrospective cross‐sectional study included 240 consecutive CTO patients who underwent coronary angiography. HALP score was calculated using the formula: hemoglobin (g/L) × albumin (g/L) × lymphocytes (/μL)/platelets (/μL). Collateral circulation was graded using the Werner classification (CC0‐CC3), with good collateral defined as a CC score ≥ 2. Correlation analysis, ROC curve analysis, and multivariate logistic regression were performed to assess the relationship between HALP score and collateral circulation. Results: The median HALP score was 4.20 (IQR: 2.68−5.68). A significant positive correlation was observed between HALP score and Werner grade ( r = 0.807, p < 0.001, R ² = 0.652). Median HALP scores increased progressively across Werner grades: CC0 (1.62), CC1 (3.20), CC2 (4.80), and CC3 (7.70). In multivariate analysis, the HALP score was significantly associated with good collateral circulation (OR: 3.762, 95% CI: 2.182−6.486, p < 0.001). The optimal cutoff of 3.509 demonstrated good diagnostic performance with 90.7% sensitivity and 66.7% specificity (AUC: 0.885). Conclusions: HALP score is significantly associated with coronary collateral circulation development in CTO patients. This simple, cost‐effective biomarker appears promising for risk stratification in this population based on this preliminary analysis, though prospective validation is needed before clinical application.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (5)
Clinical Outcomes Following PM Implantation: A 3-Year Comparative Study of Sick Sinus Syndrome and Atrioventricular Block
Background Permanent pacemaker implantation is an established treatment for both sick sinus syndrome (SSS) and atrioventricular block (AVB), yet limited data exist comparing long-term clinical outcomes and cardiac remodeling patterns between these distinct bradyarrhythmic etiologies. Objectives To compare three-year clinical outcomes and cardiac structural changes between SSS and AVB patients following permanent pacemaker implantation. Methods This retrospective observational study enrolled 192 adult patients (65 SSS, 127 AVB) who underwent pacemaker implantation between January 2018 and December 2020. Demographic data, echocardiographic parameters, pacemaker-recorded data, and clinical outcomes were assessed at baseline, one month, six months, one year, and three years. Primary outcomes included changes in cardiac structure and function, symptomatic improvement, new-onset atrial fibrillation, rehospitalization, and all-cause mortality. Results Both groups demonstrated significant declines in left ventricular ejection fraction over three years (SSS: 57.2±6.0% to 54.3±8.3%, p<0.001; AVB: 55.5±7.0% to 53.0±6.8%, p<0.001). Despite similar ventricular dysfunction progression, distinct remodeling patterns emerged: SSS patients exhibited significant increases in left atrial diameter (31.3 to 38.8 mm, p=0.040), left ventricular end-diastolic diameter (45.2 to 51.0 mm, p90%). Symptomatic improvement was comparable (SSS: 85.6% vs. AVB: 83.5%, p=0.84), as were new-onset atrial fibrillation (41.5% vs. 37.0%, p=0.54), rehospitalization (50.8% vs. 58.3%, p=0.38), and all-cause mortality (13.8% vs. 11.8%, p=0.69). Mortality predictors differed: mitral regurgitation severity in SSS versus coronary artery disease, beta-blocker therapy, and left atrial volume in AVB patients. Conclusions Despite similar symptomatic benefits and clinical outcomes, SSS and AVB patients demonstrate distinct cardiac remodeling patterns and different mortality predictors, supporting the need for etiology-specific follow-up strategies in pacemaker recipients.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (5)
Open AccessClinical Outcomes Following PM Implantation: A 3-Year Comparative Study of Sick Sinus Syndrome and Atrioventricular Block
Background Permanent pacemaker implantation is an established treatment for both sick sinus syndrome (SSS) and atrioventricular block (AVB), yet limited data exist comparing long-term clinical outcomes and cardiac remodeling patterns between these distinct bradyarrhythmic etiologies. Objectives To compare three-year clinical outcomes and cardiac structural changes between SSS and AVB patients following permanent pacemaker implantation. Methods This retrospective observational study enrolled 192 adult patients (65 SSS, 127 AVB) who underwent pacemaker implantation between January 2018 and December 2020. Demographic data, echocardiographic parameters, pacemaker-recorded data, and clinical outcomes were assessed at baseline, one month, six months, one year, and three years. Primary outcomes included changes in cardiac structure and function, symptomatic improvement, new-onset atrial fibrillation, rehospitalization, and all-cause mortality. Results Both groups demonstrated significant declines in left ventricular ejection fraction over three years (SSS: 57.2±6.0% to 54.3±8.3%, p<0.001; AVB: 55.5±7.0% to 53.0±6.8%, p<0.001). Despite similar ventricular dysfunction progression, distinct remodeling patterns emerged: SSS patients exhibited significant increases in left atrial diameter (31.3 to 38.8 mm, p=0.040), left ventricular end-diastolic diameter (45.2 to 51.0 mm, p90%). Symptomatic improvement was comparable (SSS: 85.6% vs. AVB: 83.5%, p=0.84), as were new-onset atrial fibrillation (41.5% vs. 37.0%, p=0.54), rehospitalization (50.8% vs. 58.3%, p=0.38), and all-cause mortality (13.8% vs. 11.8%, p=0.69). Mortality predictors differed: mitral regurgitation severity in SSS versus coronary artery disease, beta-blocker therapy, and left atrial volume in AVB patients. Conclusions Despite similar symptomatic benefits and clinical outcomes, SSS and AVB patients demonstrate distinct cardiac remodeling patterns and different mortality predictors, supporting the need for etiology-specific follow-up strategies in pacemaker recipients.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (5)
Resultados Clínicos após Implante de Marca-Passo: Um Estudo Comparativo de 3 Anos entre Síndrome do Nó Sinusal e Bloqueio Atrioventricular
Resumo Fundamento O implante de marca-passo permanente é um tratamento estabelecido tanto para a síndrome do nó sinusal (SNS) quanto para o bloqueio atrioventricular (BAV), porém existem poucos dados comparando os resultados clínicos a longo prazo e os padrões de remodelamento cardíaco entre essas distintas etiologias bradiarrítmicas. Objetivos Comparar os resultados clínicos e as alterações estruturais cardíacas em três anos entre pacientes com SNS e BAV após implante de marca-passo permanente. Métodos Este estudo observacional retrospectivo incluiu 192 pacientes adultos (65 com SNS, 127 com BAV) submetidos a implante de marca-passo entre janeiro de 2018 e dezembro de 2020. Dados demográficos, parâmetros ecocardiográficos, dados registrados pelo marca-passo e desfechos clínicos foram avaliados no início do estudo, após um mês, seis meses, um ano e três anos. Os desfechos primários incluíram alterações na estrutura e função cardíacas, melhora dos sintomas, fibrilação atrial de início recente, reinternação e mortalidade por todas as causas. Resultados Ambos os grupos demonstraram declínios significativos na fração de ejeção do ventrículo esquerdo ao longo de três anos (SNS: 57,2±6,0% para 54,3±8,3%, p<0,001; BAV: 55,5±7,0% para 53,0±6,8%, p<0,001). Apesar da progressão semelhante da disfunção ventricular, padrões distintos de remodelamento emergiram: os pacientes com SNS apresentaram aumentos significativos no diâmetro do átrio esquerdo (31,3 para 38,8 mm, p=0,040), no diâmetro diastólico final do ventrículo esquerdo (45,2 para 51,0 mm, p90%). A melhora dos sintomas foi comparável (SNS: 85,6% vs. BAV: 83,5%, p=0,84), assim como o surgimento de fibrilação atrial (41,5% vs. 37,0%, p=0,54), a reinternação (50,8% vs. 58,3%, p=0,38) e a mortalidade por todas as causas (13,8% vs. 11,8%, p=0,69). Os preditores de mortalidade diferiram: gravidade da regurgitação mitral em pacientes com SNS versus doença arterial coronariana, terapia com betabloqueadores e volume do átrio esquerdo em pacientes com BAV. Conclusões Apesar dos benefícios sintomáticos e resultados clínicos semelhantes, pacientes com SNS e BAV demonstram padrões distintos de remodelamento cardíaco e diferentes preditores de mortalidade, o que reforça a necessidade de estratégias de acompanhamento específicas para cada etiologia em pacientes com marca-passo.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (5)
Open AccessResultados Clínicos após Implante de Marca-Passo: Um Estudo Comparativo de 3 Anos entre Síndrome do Nó Sinusal e Bloqueio Atrioventricular
Resumo Fundamento O implante de marca-passo permanente é um tratamento estabelecido tanto para a síndrome do nó sinusal (SNS) quanto para o bloqueio atrioventricular (BAV), porém existem poucos dados comparando os resultados clínicos a longo prazo e os padrões de remodelamento cardíaco entre essas distintas etiologias bradiarrítmicas. Objetivos Comparar os resultados clínicos e as alterações estruturais cardíacas em três anos entre pacientes com SNS e BAV após implante de marca-passo permanente. Métodos Este estudo observacional retrospectivo incluiu 192 pacientes adultos (65 com SNS, 127 com BAV) submetidos a implante de marca-passo entre janeiro de 2018 e dezembro de 2020. Dados demográficos, parâmetros ecocardiográficos, dados registrados pelo marca-passo e desfechos clínicos foram avaliados no início do estudo, após um mês, seis meses, um ano e três anos. Os desfechos primários incluíram alterações na estrutura e função cardíacas, melhora dos sintomas, fibrilação atrial de início recente, reinternação e mortalidade por todas as causas. Resultados Ambos os grupos demonstraram declínios significativos na fração de ejeção do ventrículo esquerdo ao longo de três anos (SNS: 57,2±6,0% para 54,3±8,3%, p<0,001; BAV: 55,5±7,0% para 53,0±6,8%, p<0,001). Apesar da progressão semelhante da disfunção ventricular, padrões distintos de remodelamento emergiram: os pacientes com SNS apresentaram aumentos significativos no diâmetro do átrio esquerdo (31,3 para 38,8 mm, p=0,040), no diâmetro diastólico final do ventrículo esquerdo (45,2 para 51,0 mm, p90%). A melhora dos sintomas foi comparável (SNS: 85,6% vs. BAV: 83,5%, p=0,84), assim como o surgimento de fibrilação atrial (41,5% vs. 37,0%, p=0,54), a reinternação (50,8% vs. 58,3%, p=0,38) e a mortalidade por todas as causas (13,8% vs. 11,8%, p=0,69). Os preditores de mortalidade diferiram: gravidade da regurgitação mitral em pacientes com SNS versus doença arterial coronariana, terapia com betabloqueadores e volume do átrio esquerdo em pacientes com BAV. Conclusões Apesar dos benefícios sintomáticos e resultados clínicos semelhantes, pacientes com SNS e BAV demonstram padrões distintos de remodelamento cardíaco e diferentes preditores de mortalidade, o que reforça a necessidade de estratégias de acompanhamento específicas para cada etiologia em pacientes com marca-passo.
- Open Access
- 6 January 2022
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 50 (1) , 70-78
Percutaneous closure of an iatrogenic ventricular septal defect associated with transcatheter aortic valve implantation
An 81-year-old man who had dyspnea was admitted to our hospital with a diagnosis of severe aortic stenosis. A transcatheter aortic valve implantation was successfully performed with a 29 mm Edwards Sapien XT valve using a transfemoral access. After the procedure, the echocardiography showed a restrictive ventricular septal defect (VSD) in the membranous septum. As the patient had no symptoms, it was decided to follow him up conservatively. However, he was readmitted within three weeks with symptoms suggestive of biventricular failure. A control echocardiography revealed a membranous VSD, 8 mm in size, right chambers dilatation with moderate tricuspid regurgitation, and systolic pulmonary artery pressure of 60 mm Hg. The previously deployed aortic valve was normal in function. The decision to perform a percutaneous VSD closure was made. The defect was then closed with a 10 mm muscular VSD occluder. During and after the procedure, there was no dysfunction in the bioprosthetic aortic valve. At the one-year follow-up, the patient was still asymptomatic.
- 6 January 2022
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 50 (1) , 70-78
Open AccessPercutaneous closure of an iatrogenic ventricular septal defect associated with transcatheter aortic valve implantation
An 81-year-old man who had dyspnea was admitted to our hospital with a diagnosis of severe aortic stenosis. A transcatheter aortic valve implantation was successfully performed with a 29 mm Edwards Sapien XT valve using a transfemoral access. After the procedure, the echocardiography showed a restrictive ventricular septal defect (VSD) in the membranous septum. As the patient had no symptoms, it was decided to follow him up conservatively. However, he was readmitted within three weeks with symptoms suggestive of biventricular failure. A control echocardiography revealed a membranous VSD, 8 mm in size, right chambers dilatation with moderate tricuspid regurgitation, and systolic pulmonary artery pressure of 60 mm Hg. The previously deployed aortic valve was normal in function. The decision to perform a percutaneous VSD closure was made. The defect was then closed with a 10 mm muscular VSD occluder. During and after the procedure, there was no dysfunction in the bioprosthetic aortic valve. At the one-year follow-up, the patient was still asymptomatic.
- Open Access
- 3 September 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (5) , 492-499
The role of myocardial perfusion imaging in the identification of the obstructive coronary artery lesions: a tertiary cardiology center experience
Objectives: Because of the moderate accuracy of treadmill electrocardiogram and fear of a claim if a diagnosis is missed, cardiologists usually order Myocardial Perfusion Imaging (MPI) as a first-step test in most of patients with chest pain admitted to cardiology department. The performance of the MPI in diagnosing obstructive CAD depends on the population studied. Thus we aimed to assess the agreement between MPI and coronary angiography in the identification of the obstructive coronary lesion.Methods: A total of 231 patients who underwent MPI due to suspicion of coronary ischemia and had a coronary angiogram within the last three months were included in this retrospective study. MPI and coronary angiography findings were analyzed to weigh the performance of MPI in determining obstructive coronary lesion.Results: The mean age was 63.9 ± 8.9 years, 54.5% being males. MPI showed a sensitivity of 0.86 in determining patients who had a significant (> 70%) coronary lesion. While evaluating the ability of MPI to detect ischemia in the left ventricle region which is supplied by the lesioned vessel, the sensitivity was found to be; 60% in determining anterior ischemia associated with significant LAD lesion, 77.4% in determining inferior ischemia associated with significant RCA lesion, and 44.4% in determining lateral ischemia associated with significant CX lesion.Conclusions: Our findings have shown that MPI with visual assessment has 86% sensitivity for detecting significant coronary artery stenosis. However, the sensitivity of MPI in determining ischemia in the left ventricle region which is supplied by the lesioned coronary artery was found to be 44.4 to 77.4%.
- 3 September 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (5) , 492-499
Open AccessThe role of myocardial perfusion imaging in the identification of the obstructive coronary artery lesions: a tertiary cardiology center experience
Objectives: Because of the moderate accuracy of treadmill electrocardiogram and fear of a claim if a diagnosis is missed, cardiologists usually order Myocardial Perfusion Imaging (MPI) as a first-step test in most of patients with chest pain admitted to cardiology department. The performance of the MPI in diagnosing obstructive CAD depends on the population studied. Thus we aimed to assess the agreement between MPI and coronary angiography in the identification of the obstructive coronary lesion.Methods: A total of 231 patients who underwent MPI due to suspicion of coronary ischemia and had a coronary angiogram within the last three months were included in this retrospective study. MPI and coronary angiography findings were analyzed to weigh the performance of MPI in determining obstructive coronary lesion.Results: The mean age was 63.9 ± 8.9 years, 54.5% being males. MPI showed a sensitivity of 0.86 in determining patients who had a significant (> 70%) coronary lesion. While evaluating the ability of MPI to detect ischemia in the left ventricle region which is supplied by the lesioned vessel, the sensitivity was found to be; 60% in determining anterior ischemia associated with significant LAD lesion, 77.4% in determining inferior ischemia associated with significant RCA lesion, and 44.4% in determining lateral ischemia associated with significant CX lesion.Conclusions: Our findings have shown that MPI with visual assessment has 86% sensitivity for detecting significant coronary artery stenosis. However, the sensitivity of MPI in determining ischemia in the left ventricle region which is supplied by the lesioned coronary artery was found to be 44.4 to 77.4%.
- 5 May 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (7) , 1660-1663
Successful stenting of a brachial artery occlusion following surgical retrieval of a twisted diagnostic catheter during transradial coronary angiography
Coronary angiography and percutaneous coronary intervention via radial access has been progressively performed over the last three decades and has become standard of care. Even though the radial approach, compared with femoral access, is safe and is also associated with less bleeding in patients with myocardial infarction, it may be problematic in some cases. Here, we describe an 80‐year‐old woman with brachial artery dissection due to a twisted diagnostic catheter during transradial coronary angiography, who subsequently underwent surgical retrieval of the catheter.
- 5 May 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (7) , 1660-1663
Successful stenting of a brachial artery occlusion following surgical retrieval of a twisted diagnostic catheter during transradial coronary angiography
Coronary angiography and percutaneous coronary intervention via radial access has been progressively performed over the last three decades and has become standard of care. Even though the radial approach, compared with femoral access, is safe and is also associated with less bleeding in patients with myocardial infarction, it may be problematic in some cases. Here, we describe an 80‐year‐old woman with brachial artery dissection due to a twisted diagnostic catheter during transradial coronary angiography, who subsequently underwent surgical retrieval of the catheter.
- 4 September 2019
- Published by Springer Nature in Herz
- Vol. 45 (4) , 389-396
Prognostic value of serum uric acid levels in patients with non-STEMI undergoing percutaneous coronary intervention
Because myocardial infarction in young adults is rare, there has been limited research on the condition in this patient group. Very few data are available regarding the long-term outcomes of patients under 40 years of age with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing invasive treatments. The prognostic value of uric acid (UA) in young patients with NSTEMI who undergo percutaneous coronary intervention (PCI) has also not been studied. The purpose of this study was to evaluate the long-term clinical outcomes of this specific subset of young patients. In addition, we aimed to identify the role of serum UA in predicting the long-term prognosis of young patients with NSTEMI who have undergone PCI.
- 4 September 2019
- Published by Springer Nature in Herz
- Vol. 45 (4) , 389-396
Prognostic value of serum uric acid levels in patients with non-STEMI undergoing percutaneous coronary intervention
Because myocardial infarction in young adults is rare, there has been limited research on the condition in this patient group. Very few data are available regarding the long-term outcomes of patients under 40 years of age with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing invasive treatments. The prognostic value of uric acid (UA) in young patients with NSTEMI who undergo percutaneous coronary intervention (PCI) has also not been studied. The purpose of this study was to evaluate the long-term clinical outcomes of this specific subset of young patients. In addition, we aimed to identify the role of serum UA in predicting the long-term prognosis of young patients with NSTEMI who have undergone PCI.